HK1218255A1 - 包含度他雄胺的口服軟膠囊製劑 - Google Patents
包含度他雄胺的口服軟膠囊製劑Info
- Publication number
- HK1218255A1 HK1218255A1 HK16106274.6A HK16106274A HK1218255A1 HK 1218255 A1 HK1218255 A1 HK 1218255A1 HK 16106274 A HK16106274 A HK 16106274A HK 1218255 A1 HK1218255 A1 HK 1218255A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dutasteride
- soft capsule
- capsule formulation
- oral soft
- oral
- Prior art date
Links
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 title 1
- 229960004199 dutasteride Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000007901 soft capsule Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130075884 | 2013-06-28 | ||
KR1020140038291A KR101833280B1 (ko) | 2013-06-28 | 2014-03-31 | 두타스테라이드를 포함하는 경구용 연질 캡슐 제형 |
PCT/KR2014/005753 WO2014209062A1 (en) | 2013-06-28 | 2014-06-27 | Oral soft capsule formulation comprising dutasteride |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1218255A1 true HK1218255A1 (zh) | 2017-02-10 |
Family
ID=52475856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16106274.6A HK1218255A1 (zh) | 2013-06-28 | 2016-06-02 | 包含度他雄胺的口服軟膠囊製劑 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3013328B1 (zh) |
JP (1) | JP6051334B2 (zh) |
KR (1) | KR101833280B1 (zh) |
ES (1) | ES2694833T3 (zh) |
HK (1) | HK1218255A1 (zh) |
WO (1) | WO2014209062A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101833280B1 (ko) | 2013-06-28 | 2018-02-28 | 한미약품 주식회사 | 두타스테라이드를 포함하는 경구용 연질 캡슐 제형 |
KR101590072B1 (ko) * | 2014-12-23 | 2016-01-29 | 한미약품 주식회사 | 두타스테라이드를 포함하는 자가유화 약물전달 시스템용 조성물 |
KR102503428B1 (ko) * | 2015-12-22 | 2023-02-24 | 한미약품 주식회사 | 두타스테라이드를 포함하는 경구용 연질 캡슐 제형용 포장재 |
KR101716878B1 (ko) * | 2016-05-12 | 2017-03-15 | 주식회사 유유제약 | 글리세롤 지방산에스테르유도체 또는 프로필렌글리콜 지방산에스테르유도체를 함유한 두타스테리드와 타다라필의 복합 캡슐제제 조성물 및 이의 제조방법 |
KR102281252B1 (ko) | 2018-05-21 | 2021-07-23 | (주)인벤티지랩 | 두타스테라이드를 포함하는 마이크로 입자 및 이의 제조 방법 |
WO2019225924A1 (ko) * | 2018-05-21 | 2019-11-28 | (주)인벤티지랩 | 두타스테라이드를 포함하는 마이크로 입자 및 이의 제조 방법 |
JP2020055766A (ja) * | 2018-10-01 | 2020-04-09 | 東洋カプセル株式会社 | デュタステリドを含有する軟カプセル剤 |
CN111388441A (zh) * | 2018-12-13 | 2020-07-10 | 昆明积大制药股份有限公司 | 度他雄胺软胶囊 |
CN110613695A (zh) * | 2019-10-23 | 2019-12-27 | 人福普克药业(武汉)有限公司 | 一种度他雄胺软胶囊及其制备方法 |
CN111621032B (zh) * | 2020-04-27 | 2022-04-05 | 上海海洋大学 | 辛烯基琥珀酸酐修饰的明胶及其制备方法和应用 |
KR102199667B1 (ko) * | 2020-08-14 | 2021-01-07 | (주)필인터내셔널 | 두타스테리드를 포함하는 약학적 조성물 |
CN111759821B (zh) * | 2020-08-24 | 2021-10-08 | 四川奥邦投资有限公司 | 一种度他雄胺软胶囊药物组合物 |
KR20240011623A (ko) | 2022-07-19 | 2024-01-26 | (주)인벤티지랩 | 두타스테라이드를 포함하는 서방성 주사용 조성물 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2650578B2 (ja) * | 1992-08-27 | 1997-09-03 | 日本エランコ株式会社 | 硬質カプセル用ゼラチン皮膜組成物及び易溶性硬質ゼラチンカプセル |
JPH07252138A (ja) * | 1995-01-13 | 1995-10-03 | Nippon Eranko Kk | 易溶性硬質ゼラチンカプセル |
WO1997033568A1 (en) * | 1996-03-12 | 1997-09-18 | Novartis Ag | Filled gelatin capsules having a reduced degree of cross-linking |
JP2000044465A (ja) * | 1998-05-28 | 2000-02-15 | Fuji Capsule Kk | 軟カプセル剤 |
EP1549299B1 (en) * | 2002-06-05 | 2014-08-20 | IVAX Pharmaceuticals s.r.o. | Reduction of gelatin cross-linking |
ES2389353T3 (es) * | 2008-06-10 | 2012-10-25 | Teva Pharmaceutical Industries Ltd. | Cápsulas de gelatina blanda de rasagilina |
KR20090130580A (ko) | 2008-06-16 | 2009-12-24 | 알앤피코리아주식회사 | 제제학적으로 안정한 츄어블 연질캡슐 조성물 |
EP2395975A4 (en) * | 2009-02-10 | 2013-05-22 | Genepharm India Private Ltd | ORAL PHARMACEUTICAL COMPOSITION OF DUTASTERIDE |
WO2010124039A1 (en) * | 2009-04-24 | 2010-10-28 | Glaxosmithkline Llc | Methods of administering dutasteride |
KR101055412B1 (ko) * | 2010-11-19 | 2011-08-08 | (주)비씨월드제약 | 두타스테라이드를 포함하는 자가유화 에멀젼 조성물 및 이의 제조방법 |
KR101833280B1 (ko) | 2013-06-28 | 2018-02-28 | 한미약품 주식회사 | 두타스테라이드를 포함하는 경구용 연질 캡슐 제형 |
-
2014
- 2014-03-31 KR KR1020140038291A patent/KR101833280B1/ko active IP Right Grant
- 2014-06-27 ES ES14817963.3T patent/ES2694833T3/es active Active
- 2014-06-27 EP EP14817963.3A patent/EP3013328B1/en active Active
- 2014-06-27 WO PCT/KR2014/005753 patent/WO2014209062A1/en active Application Filing
- 2014-06-27 JP JP2016504265A patent/JP6051334B2/ja not_active Expired - Fee Related
-
2016
- 2016-06-02 HK HK16106274.6A patent/HK1218255A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2014209062A1 (en) | 2014-12-31 |
JP2016514724A (ja) | 2016-05-23 |
KR101833280B1 (ko) | 2018-02-28 |
EP3013328B1 (en) | 2018-10-17 |
JP6051334B2 (ja) | 2016-12-27 |
EP3013328A1 (en) | 2016-05-04 |
EP3013328A4 (en) | 2016-11-23 |
KR20150002446A (ko) | 2015-01-07 |
ES2694833T3 (es) | 2018-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1218255A1 (zh) | 包含度他雄胺的口服軟膠囊製劑 | |
IL245796B (en) | The composition for oral care | |
HRP20190173T1 (hr) | Oralne formulacije deferasiroksa | |
IL246377A0 (en) | Pharmaceutical preparations for oral administration | |
IL245855B (en) | Oral formulations of pyrrolidine derivatives | |
ZA201604695B (en) | Oral care compositions and methods | |
EP2977052A4 (en) | AGENT FOR LIFESTYLE-RELATED DISEASE AND ORAL COMPOSITION COMPRISING THE SAME | |
IL245820A0 (en) | Compositions and methods for oral care | |
EP3013326A4 (en) | COVERING COMPOSITIONS FOR SOFT CAPSULES AND SOFT CAPSULES | |
IL245700A0 (en) | Compositions for oral care | |
IL245777A0 (en) | The vehicle for oral treatment to prevent stench | |
ZA201604306B (en) | Oral care compositions and methods | |
ZA201604303B (en) | Oral care compositions and methods | |
SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
HK1202048A1 (zh) | 牙用膠囊 | |
GB201305103D0 (en) | An oral dosage form | |
HK1215561A1 (zh) | 劑量膠囊 | |
GB2520315B (en) | Oral Syringes | |
HK1219225A1 (zh) | 口腔護理組合物 | |
HU4589U (en) | Capsule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230624 |